http://www.tapanray.in A Tapan Ray Website Sun, 22 Mar 2026 10:59:18 +0000 en-US hourly 1 http://wordpress.org/?v=3.4.2 http://www.tapanray.in/physicians-increasing-digital-proficiency-and-its-implication/?utm_source=rss&utm_medium=rss&utm_campaign=physicians-increasing-digital-proficiency-and-its-implication http://www.tapanray.in/physicians-increasing-digital-proficiency-and-its-implication/#comments Mon, 07 Feb 2022 00:00:20 +0000 Tapan Ray http://www.tapanray.in/?p=10650 Continue reading →]]> http://www.tapanray.in/physicians-increasing-digital-proficiency-and-its-implication/feed/ 0 http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/?utm_source=rss&utm_medium=rss&utm_campaign=covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/#comments Mon, 26 Apr 2021 00:00:54 +0000 Tapan Ray http://www.tapanray.in/?p=10482 Continue reading →]]> http://www.tapanray.in/covid-2-0-rampages-india-as-top-echelon-policy-makers-ignore-science/feed/ 0 http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/?utm_source=rss&utm_medium=rss&utm_campaign=aptness-of-pharma-marketing-audit-in-covid-days-and-beyond http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/#comments Mon, 21 Sep 2020 00:00:13 +0000 Tapan Ray http://www.tapanray.in/?p=10266 Continue reading →]]> http://www.tapanray.in/aptness-of-pharma-marketing-audit-in-covid-days-and-beyond/feed/ 0 http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/?utm_source=rss&utm_medium=rss&utm_campaign=draft-pharma-policy-2017-and-branded-generics http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/#comments Sun, 27 Aug 2017 23:55:24 +0000 Tapan Ray http://www.tapanray.in/?p=8385 Continue reading →]]> http://www.tapanray.in/draft-pharma-policy-2017-and-branded-generics/feed/ 0 http://www.tapanray.in/india-china-revoke-four-pharma-patents-in-a-fortnight-a-double-whammy-for-mncs/?utm_source=rss&utm_medium=rss&utm_campaign=india-china-revoke-four-pharma-patents-in-a-fortnight-a-double-whammy-for-mncs http://www.tapanray.in/india-china-revoke-four-pharma-patents-in-a-fortnight-a-double-whammy-for-mncs/#comments Mon, 12 Aug 2013 00:00:58 +0000 Tapan Ray http://www.tapanray.in/?p=3326 Continue reading →]]> http://www.tapanray.in/india-china-revoke-four-pharma-patents-in-a-fortnight-a-double-whammy-for-mncs/feed/ 0 http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/?utm_source=rss&utm_medium=rss&utm_campaign=pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/#comments Mon, 08 Jul 2013 00:00:54 +0000 Tapan Ray http://www.tapanray.in/?p=2883 Continue reading →]]> http://www.tapanray.in/pioglitazone-conundrum-should-the-drug-regulator-step-over-the-line/feed/ 0 http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/?utm_source=rss&utm_medium=rss&utm_campaign=balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/#comments Mon, 01 Jul 2013 00:00:39 +0000 Tapan Ray http://www.tapanray.in/?p=2691 Continue reading →]]> http://www.tapanray.in/balancing-ipr-with-public-health-interest-brickbats-power-play-and-bouquets/feed/ 0